Andrew Saik - Chief Financial Officer at VYNE Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
VYNE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew Saik since 12/22/2023

Holdings reported by Andrew Saik for VYNE Therapeutics Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 116K $266K $2.28 May 28, 2021 Direct

Transactions reported by Andrew Saik for VYNE Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.